Press Release
– Positive Full Results from Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Exceed Aclaris’ Target Profile, Validating Potential Best-in-Class Potency Advantage and Opportunity…
Dublin, April 28, 2026 (GLOBE NEWSWIRE) — The “Satellite Modem…
Dublin, April 28, 2026 (GLOBE NEWSWIRE) — The “Feed Acidulants…
Washington, DC, April 15, 2026 (GLOBE NEWSWIRE) — The Association for Frontotemporal Degeneration (AFTD) hosted its…
KEY POINTS Global Recognition: ASUS is named in Clean200 for four consecutive years and is…
INDIANA, Pa., April 15, 2026 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation today announced Ryan…
ATLANTA, April 15, 2026 (GLOBE NEWSWIRE) — Monarch Private Capital (“Monarch”), a national leader in…
Medford, OR, April 15, 2026 (GLOBE NEWSWIRE) — Next Wednesday, April 22, 2026, The Human…
LONDON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the…